rss
Br J Ophthalmol 2003;87:523-524 doi:10.1136/bjo.87.5.523
  • Commentary

Is Chlamydia pneumoniae infection a risk factor for age related macular degeneration?

  1. O Ishida1,
  2. H Oku1,
  3. T Ikeda1,
  4. M Nishimura2,
  5. K Kawagoe3,
  6. K Nakamura4
  1. 1Osaka Medical College, Osaka, Japan
  2. 2Kyoto Prefectural University of Medicine, Kyoto, Japan
  3. 3Hitachi Chemical Co Ltd, Japan
  4. 4Nakamura Eye Clinic, Japan
  1. Correspondence to: Hidehiro Oku, Osaka Medical College, Osaka, Japan; hidehirooku{at}aol.com
  • Accepted 21 December 2002

The association between a pathogen and AMD is worth further investigation because a new approach might treat this incurable vision threatening disease

Age related macular degeneration (AMD) is a leading cause of decreased central vision in older people throughout the world. The pathogenesis of AMD is very complex and has still not been determined. In addition to some genetic and environmental factors, several kinds of risk factors have been proposed; sunlight exposure,1 smoking,2 and low levels of nutritional components such as antioxidants.3 Hypertension,4 hyperlipidaemia,4 and atherosclerosis,5,6 which may lead to cardiovascular diseases, are also considered to be risk factors.

Chronic inflammatory events have recently been identified as plausible causes of atherosclerosis. In particular, much interest has been focused on infections by Chlamydia pneumoniae, which was previously known as the TWAR strain. This strain is one of the chlamydial species that has been recognised as a causal mediator of respiratory infections such as bronchitis, pneumonia, and upper respiratory tract infections.7

Chlamydia can multiply in various host cells including macrophages and endothelial cells.8C pneumoniae is like a parasite and consumes energy that is needed by the host cells and, in the end, destroys them and then infects nearby cells. Thus, the pathogens tend to cause a chronic infection.

The first study showing a positive interaction between systemic vascular disease and infection with C pneumoniae was made by Saikku et al in 1988.9 They reported increased immunoglobulin G (IgG) and IgA antibody titres against C pneumoniae in male patients with myocardial infarction or chronic coronary heart disease. Since then, attention has been focused on its association with atherosclerotic diseases.10 A strong piece of evidence indicating a close interaction between C pneumoniae …

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of BJO.
View free sample issue >>

Free archive
The full back archive is now available for BJO. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006, back to volume 1 issue 1.
Register to access the free archive >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.